• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

声诺维增强超声检查:与疑似肝细胞癌患者的CT/MRI肝脏影像报告和数据系统的比较

Sonazoid-enhanced ultrasonography: comparison with CT/MRI Liver Imaging Reporting and Data System in patients with suspected hepatocellular carcinoma.

作者信息

Hwang Jeong Ah, Jeong Woo Kyoung, Min Ji Hye, Kim Yeun-Yoon, Heo Nam Hun, Lim Hyo Keun

机构信息

Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Ultrasonography. 2021 Oct;40(4):486-498. doi: 10.14366/usg.20120. Epub 2021 Jan 15.

DOI:10.14366/usg.20120
PMID:33745266
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8446493/
Abstract

PURPOSE

The aim of this study was to evaluate the association of contrast-enhanced ultrasound (CEUS) features using Sonazoid for liver nodules with Liver Imaging Reporting and Data System (LI-RADS) categories and to identify the usefulness of Kupffer-phase images.

METHODS

This retrospective study was conducted in 203 patients at high risk of hepatocellular carcinoma (HCC) who underwent CEUS with Sonazoid from 2013 to 2016. Nodule enhancement in the arterial, portal venous, late, and Kupffer phases; CEUS LI-RADS major features; and Kupffer-phase defects were evaluated. According to the computed tomography/magnetic resonance imaging (CT/MRI) LI-RADS v2018, all nodules were assigned an LR category (n=4/33/99/67 for LR-M/3/4/5) and comparisons across LR categories were made. We defined modified CEUS LI-RADS as using Kupffer-phase defects as an alternative to late and mild washout in CEUS LI-RADS and compared the diagnostic performance for HCC.

RESULTS

On CEUS of 203 nodules, 89.6% of CT/MRI LR-5 and 85.9% of LR-4 nodules showed hyperenhancement in the arterial phase, while 57.6% of LR-3 nodules showed hyperenhancement. Among the CT/MRI LR-5 nodules that showed arterial phase hyperenhancement or isoenhancement, 59.7% showed hypoenhancing changes from the portal venous phase, 23.9% from the late phase, and 13.4% additionally in the Kupffer phase. The modified CEUS LI-RADS showed higher sensitivity than CEUS LI-RADS (83.2% vs. 74.2%, P=0.008) without compromising specificity (63.6% vs. 69.7%, P=0.500).

CONCLUSION

The Kupffer phase best shows hypoenhancing changes in LR-5 lesions and is expected to improve the sensitivity for HCC in high-risk patients.

摘要

目的

本研究旨在评估使用声诺维进行肝脏结节超声造影(CEUS)的特征与肝脏影像报告和数据系统(LI-RADS)分类之间的相关性,并确定库普弗期图像的有用性。

方法

本回顾性研究纳入了2013年至2016年期间接受声诺维CEUS检查的203例肝细胞癌(HCC)高危患者。评估动脉期、门静脉期、延迟期和库普弗期的结节强化情况;CEUS LI-RADS主要特征;以及库普弗期缺损。根据计算机断层扫描/磁共振成像(CT/MRI)LI-RADS v2018,所有结节被指定一个LR类别(LR-M/3/4/5分别为n = 4/33/99/67),并对不同LR类别进行比较。我们将改良的CEUS LI-RADS定义为使用库普弗期缺损替代CEUS LI-RADS中的延迟期和轻度廓清,并比较其对HCC的诊断性能。

结果

在203个结节的CEUS检查中,89.6%的CT/MRI LR-5结节和85.9%的LR-4结节在动脉期表现为高增强,而57.6%的LR-3结节表现为高增强。在CT/MRI LR-5结节中,表现为动脉期高增强或等增强的结节中,59.7%在门静脉期出现低增强变化,23.9%在延迟期出现,13.4%在库普弗期额外出现。改良的CEUS LI-RADS显示出比CEUS LI-RADS更高的敏感性(83.2%对74.2%,P = 0.008),且不影响特异性(63.6%对69.7%,P = 0.500)。

结论

库普弗期最能显示LR-5病变的低增强变化,有望提高高危患者HCC的敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b4b/8446493/163b8c77a40a/usg-20120f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b4b/8446493/30ca30df8b85/usg-20120f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b4b/8446493/3afef8295426/usg-20120f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b4b/8446493/17e0765cc28f/usg-20120f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b4b/8446493/4a43ca49d84c/usg-20120f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b4b/8446493/163b8c77a40a/usg-20120f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b4b/8446493/30ca30df8b85/usg-20120f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b4b/8446493/3afef8295426/usg-20120f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b4b/8446493/17e0765cc28f/usg-20120f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b4b/8446493/4a43ca49d84c/usg-20120f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b4b/8446493/163b8c77a40a/usg-20120f5.jpg

相似文献

1
Sonazoid-enhanced ultrasonography: comparison with CT/MRI Liver Imaging Reporting and Data System in patients with suspected hepatocellular carcinoma.声诺维增强超声检查:与疑似肝细胞癌患者的CT/MRI肝脏影像报告和数据系统的比较
Ultrasonography. 2021 Oct;40(4):486-498. doi: 10.14366/usg.20120. Epub 2021 Jan 15.
2
Usefulness of Modified CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma Using Sonazoid.改良CEUS LI-RADS在使用Sonazoid诊断肝细胞癌中的应用价值
Diagnostics (Basel). 2020 Oct 15;10(10):828. doi: 10.3390/diagnostics10100828.
3
Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection.使用全氟丁烷的超声造影:拟议改良 LI-RADS 标准对肝细胞癌检测的影响。
AJR Am J Roentgenol. 2022 Sep;219(3):434-443. doi: 10.2214/AJR.22.27521. Epub 2022 Apr 20.
4
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.在一项多中心回顾性研究中,1006 个结节的对比超声 LI-RADS LR-5 可识别肝硬化中的肝细胞癌。
J Hepatol. 2018 Mar;68(3):485-492. doi: 10.1016/j.jhep.2017.11.007. Epub 2017 Nov 11.
5
Intraindividual Comparison of Contrast-Enhanced Ultrasound Using Perfluorobutane With Modified Criteria Versus CT/MRI LI-RADS Version 2018 for Diagnosing HCC in High-Risk Patients.应用改良标准对比增强超声造影与 CT/MRI LI-RADS Version 2018 对高危人群 HCC 进行诊断的个体内比较。
AJR Am J Roentgenol. 2023 May;220(5):682-691. doi: 10.2214/AJR.22.28420. Epub 2022 Nov 16.
6
Comparison of modified CEUS LI-RADS with sonazoid and CT/MRI LI-RADS for diagnosis of hepatocellular carcinoma.改良的超声造影肝脏影像报告和数据系统(CEUS LI-RADS)与声诺维及CT/MRI肝脏影像报告和数据系统(LI-RADS)在肝细胞癌诊断中的比较
Hepatol Res. 2022 Aug;52(8):730-738. doi: 10.1111/hepr.13793. Epub 2022 May 28.
7
The efficacy of modified contrast-enhanced ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) using Sonazoid in diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis.使用声诺维的改良对比增强超声肝脏影像报告和数据系统(CEUS LI-RADS)在肝细胞癌诊断中的疗效:一项系统评价和荟萃分析。
Quant Imaging Med Surg. 2024 Apr 3;14(4):2927-2937. doi: 10.21037/qims-23-1184. Epub 2024 Mar 21.
8
Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.超声造影对肝细胞癌鉴别诊断的诊断准确性:爱克发与CEUS-LI-RADS对比
Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1036-1044. doi: 10.1097/MEG.0000000000000916.
9
Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.CEUS LI-RADS 在肝癌风险患者中对 20mm 或更小的肝脏结节的特征诊断准确性。
Radiology. 2020 Feb;294(2):329-339. doi: 10.1148/radiol.2019191086. Epub 2019 Dec 3.
10
Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS.肝细胞癌风险患者中非肝细胞癌恶性肿瘤的诊断:对比增强超声LI-RADS与CT/MRI LI-RADS
Front Oncol. 2021 Apr 12;11:641195. doi: 10.3389/fonc.2021.641195. eCollection 2021.

引用本文的文献

1
Echo contrast medium: How the use of contrast echocardiography (ultrasound contrast agents) can improve patient care.超声造影剂:超声心动图造影(超声造影剂)的应用如何改善患者护理。
World J Methodol. 2025 Sep 20;15(3):100490. doi: 10.5662/wjm.v15.i3.100490.
2
Differentiation of AFP-negative hepatocellular carcinoma from other intrahepatic malignant lesions by a noninvasive predictive model based on Sonazoid contrast-enhanced ultrasound.基于Sonazoid对比增强超声的非侵入性预测模型对甲胎蛋白阴性肝细胞癌与其他肝内恶性病变的鉴别诊断
Front Oncol. 2025 Jul 17;15:1623670. doi: 10.3389/fonc.2025.1623670. eCollection 2025.
3

本文引用的文献

1
Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging.使用磁共振成像对肝细胞癌进行无创诊断时LI-RADS 2018与KLCA-NCC 2018的比较
Clin Mol Hepatol. 2020 Jul;26(3):340-351. doi: 10.3350/cmh.2020.0004. Epub 2020 Jun 4.
2
LI-RADS ancillary features on contrast-enhanced ultrasonography.超声造影检查中的肝脏影像报告和数据系统(LI-RADS)辅助特征
Ultrasonography. 2020 Jul;39(3):221-228. doi: 10.14366/usg.19052. Epub 2020 May 9.
3
The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid.
Perfluorobutane Nanodroplets for the Selective Sensing and Range Verification of Carbon-Ion Radiotherapy: In Vitro Evaluation on Cells.
用于碳离子放射治疗的选择性传感和射程验证的全氟丁烷纳米液滴:细胞的体外评估
ACS Omega. 2025 Jun 30;10(27):29154-29165. doi: 10.1021/acsomega.5c01785. eCollection 2025 Jul 15.
4
Size-Sorted Superheated Nanodroplets for Dosimetry and Range Verification of Carbon-Ion Radiotherapy.用于碳离子放射治疗剂量测定和射程验证的尺寸分选过热纳米液滴
Nanomaterials (Basel). 2024 Oct 13;14(20):1643. doi: 10.3390/nano14201643.
5
Management Consensus Guidelines for Hepatocellular Carcinoma: 2023 Update on Surveillance, Diagnosis, Systemic Treatment, and Posttreatment Monitoring by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.肝细胞癌管理共识指南:台湾肝癌协会和台湾胃肠病学会2023年关于监测、诊断、全身治疗及治疗后监测的更新
Liver Cancer. 2024 Feb 12;13(5):468-486. doi: 10.1159/000537686. eCollection 2024 Oct.
6
The American College of Radiology contrast-enhanced ultrasound Liver Imaging Reporting and Data System and its modified version in diagnosing hepatocellular carcinoma via Sonazoid: a meta-analysis.美国放射学会对比增强超声肝脏影像报告和数据系统及其改良版本在通过声诺维诊断肝细胞癌中的应用:一项荟萃分析。
Quant Imaging Med Surg. 2024 Jul 1;14(7):4555-4566. doi: 10.21037/qims-23-1459. Epub 2024 Jun 27.
7
Value of Sonazoid-enhanced ultrasonography in characterizing indeterminate focal liver lesions on gadoxetic acid-enhanced liver MRI in patients without risk factors for hepatocellular carcinoma.钆塞酸增强磁共振成像中对无肝细胞癌危险因素患者局灶性肝脏病变性质不确定的超声造影表现评估。
PLoS One. 2024 May 24;19(5):e0304352. doi: 10.1371/journal.pone.0304352. eCollection 2024.
8
Compared with SonoVue LR-5, Sonazoid modified LR-5 has better diagnostic sensitivity for hepatocellular carcinoma: a systematic review and meta-analysis.与声诺维LR-5相比,Sonazoid改良的LR-5对肝细胞癌具有更好的诊断敏感性:一项系统评价和荟萃分析。
Quant Imaging Med Surg. 2024 Apr 3;14(4):2978-2992. doi: 10.21037/qims-23-1616. Epub 2024 Mar 13.
9
The efficacy of modified contrast-enhanced ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) using Sonazoid in diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis.使用声诺维的改良对比增强超声肝脏影像报告和数据系统(CEUS LI-RADS)在肝细胞癌诊断中的疗效:一项系统评价和荟萃分析。
Quant Imaging Med Surg. 2024 Apr 3;14(4):2927-2937. doi: 10.21037/qims-23-1184. Epub 2024 Mar 21.
10
Intra-individual comparison of Sonazoid contrast-enhanced ultrasound and SonoVue contrast-enhanced ultrasound in diagnosing hepatocellular carcinoma.超声造影剂声诺维与声诺美增强超声在诊断肝细胞癌中的个体内比较。
Abdom Radiol (NY). 2024 May;49(5):1432-1443. doi: 10.1007/s00261-024-04250-7. Epub 2024 Apr 7.
AFSUMB关于使用声诺维进行超声造影临床实践的共识声明与建议。
Ultrasonography. 2020 Jul;39(3):191-220. doi: 10.14366/usg.20057. Epub 2020 Apr 27.
4
Contrast-enhanced ultrasound approach to the diagnosis of focal liver lesions: the importance of washout.超声造影在肝脏局灶性病变诊断中的应用:廓清的重要性
Ultrasonography. 2019 Oct;38(4):289-301. doi: 10.14366/usg.19006. Epub 2019 Mar 17.
5
Contrast-enhanced US with Perfluorobutane for Hepatocellular Carcinoma Surveillance: A Multicenter Diagnostic Trial (SCAN).对比增强超声造影剂氟丙烷在肝细胞癌监测中的应用:一项多中心诊断试验(SCAN)
Radiology. 2019 Sep;292(3):638-646. doi: 10.1148/radiol.2019190183. Epub 2019 Jul 9.
6
2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.2018 韩国肝癌协会-韩国国家癌症中心肝细胞癌管理实践指南。
Korean J Radiol. 2019 Jul;20(7):1042-1113. doi: 10.3348/kjr.2019.0140.
7
Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand?肝细胞癌的超声造影:我们目前的进展如何?
Ultrasonography. 2019 Jul;38(3):200-214. doi: 10.14366/usg.18060. Epub 2019 Feb 25.
8
Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.高危人群肝细胞癌无创诊断标准化算法的观察者间和模态间一致性:CEUS-LI-RADS 与 MRI-LI-RADS。
Eur Radiol. 2018 Oct;28(10):4254-4264. doi: 10.1007/s00330-018-5379-1. Epub 2018 Apr 19.
9
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.在一项多中心回顾性研究中,1006 个结节的对比超声 LI-RADS LR-5 可识别肝硬化中的肝细胞癌。
J Hepatol. 2018 Mar;68(3):485-492. doi: 10.1016/j.jhep.2017.11.007. Epub 2017 Nov 11.
10
Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system.对比增强超声(CEUS)肝脏影像报告和数据系统(LI-RADS)2017 - 与 CT/MRI 系统相比的重要差异综述。
Clin Mol Hepatol. 2017 Dec;23(4):280-289. doi: 10.3350/cmh.2017.0037. Epub 2017 Sep 15.